CCL2 and neoplasm: To identify candidate stroma-derived factors that might influence desmoid tumor cell proliferation, we treated mutant-only cultures with recombinant IGFBP3, PTX3, CCL2, CXCL12, and CHI3L1 in serum-free conditions.